Please login to the form below
Excellence in oncology: Developing an effective biomarker strategy
Oncology is arguably the most exciting area of medicine in which to be working today. Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients.
Oncology is arguably the most exciting area of medicine in which to be working today. Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients. Payers are able to demonstrate that the treatment they are paying for will be of maximum value. Physicians feel confident that they are offering an effective drug, which is at the cutting-edge of medicine. And patients clearly benefit from a treatment programme that reduces the risk of unnecessary toxicities and offers them better outcomes.
Manufacturers with an innovator drug now in development will usually search for a suitable biomarker to launch alongside the drug. It is critical that manufacturers develop an effective launch/ marketing strategy for their biomarker in order to maximise uptake of their oncology brand.
Download and read the complimentary whitepaper at http://bit.ly/1LhmjYr
We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges.
Manufacturers with an innovator drug now in development will usually search for a suitable biomarker to launch alongside the drug. It is critical that manufacturers develop an effective launch/ marketing strategy for their biomarker in order to maximise uptake of their oncology brand.
Download and read the complimentary whitepaper at http://bit.ly/1LhmjYr
We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges.
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Video: Strategic engagement case study
- Supporting the launch of a global vaccine with a programme of market research and strategic insights
Research Partnership
- Webinar: The virtual patient: How to use AI-powered conjoint to understand complex treatment decisions
- Register to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes.
Research Partnership
- Research Partnership appoints new CEO
- Research Partnership has appointed Gareth Phillips to take over as CEO
Research Partnership
- Infographic: Therapy Watch Hyperlipidaemia
- Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study.
Research Partnership
- Article: The rise of the healthcare influencer
- In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space.
Research Partnership
- How to elevate your communications testing with AI powered insights and analytics
- Learn about a new behavioural science-led framework incorporating AI technologies that ensures you get a true reflection of how your communications materials are consumed and processed by customers
Research Partnership
